Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC Vs. Placebo + SOC in Adult Hospitalized Patients with COVID-19 [Phase 2, Phase 3]

View source ↗

Summary

A randomized, double-blind trial evaluating EB05 plus standard of care versus placebo plus standard of care in hospitalized adults with COVID-19/acute respirato…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• EB05

Snippet

Sponsor: Edesa Biotech Inc. | Conditions: COVID-19, ARDS | Phase 2, Phase 3 | Status: SUSPENDED